ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2019 American Transplant Congress

    Development and Implementation of a Pediatric Transplant Consortium

    K. Soltys1, S. K. Rassmussen2, J. Squires3, R. Sindhi1, S. Pelletier2, K. Brayman2, M. Angelis4, T. Chin4, R. Teaster2, J. Oberholzer2, R. Gonzalez-Peralta5, B. Friedman4, D. Hupp6, M. Mendoza7, P. A. Eicker6, J. Middleton7, G. Mazariegos1

    1Transplant Surgery, Childrens Hospital of Pittsburgh of UPMC, Pittsburgh, PA, 2Charles O. Strickler Transplant Center, University of Virginia, Charlottesville, VA, 3Hepatology, Childrens Hospital of Pittsburgh of UPMC, Pittsburgh, PA, 4AdventHealth Transplant Institute, Florida Hospital, Orlando, FL, 5AdventHealth for Children, Florida Hospital, Orlando, FL, 6Nursing, Childrens Hospital of Pittsburgh of UPMC, Pittsburgh, PA, 7Hepatology, University of Virginia, Charlottesville, VA

    *Purpose: Access to pediatric liver transplant expertise varies nationally and variability in practice leads to potential suboptimal organ utilization and outcomes. A multi-institutional collaborative was…
  • 2019 American Transplant Congress

    Independent Risk Factors for Discard of Pediatric Liver Allografts

    T. H. Malik1, J. Goss2, N. T. Galvan2, M. L. Kueht II2, A. Rana3

    1Department of Student Affairs, Baylor College of Medicine, Houston, TX, 2Department of Abdominal Transplantation, Baylor College of Medicine, Houston, TX, 3Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX

    *Purpose: The aim of this study is to identify risk factors available at the time of initial DonorNet offer to predict discard of pediatric liver…
  • 2019 American Transplant Congress

    Assessment Of Glomerular Filtration Rate Among Lung Transplant Candidates

    S. Akkina1, S. Hou2, D. Jain Arwindekar2, A. Desai2

    1Loyola University Medical Center, Maywood, IL, 2Medicine, Loyola University Medical Center, Maywood, IL

    *Purpose: Assessment of kidney function in lung transplant candidates is difficult due to cachexia prior to transplant. Measured glomerular filtration rate (GFR) studies are useful…
  • 2019 American Transplant Congress

    Surgical Site Complications in Kidney Transplant Recipients: Incidence and Outcomes in the Modern Era

    J. S. Kim

    Toronto General Hospital, Toronto, ON, Canada

    *Purpose: Post-transplant immunosuppressive regimens may compromise wound healing, including at the surgical site. Transplant recipients are therefore especially susceptible to surgical site complications (SSC), such…
  • 2019 American Transplant Congress

    Single-Port Robotic Kidney Transplantation: Initial Pre-Clinical Experience Using the SP Surgical System

    M. Eltemamy, J. Garisto, R. Bertolo, E. Miller, A. Wee, J. Kaouk

    Cleveland Clinic, Cleveland, OH

    *Purpose: Multiport robotic kidney transplantation has been described as a novel minimally invasive approach. We evaluate the feasibility of a robot-assisted single-port kidney transplantation using…
  • 2019 American Transplant Congress

    Performance Improvement Initiative: Ambulatory Tool to Improve Tacrolimus Intrapatient Variability (IPV) Monitoring in Kidney & Liver Transplant Recipients

    T. E. Kaiser1, N. S. Ejaz1, S. Tremblay1, N. J. Parrish2, S. Schinasi2, J. Harris2, A. Govil1, N. Anwar1, R. R. Alloway1

    1University of Cincinnati, Cincinnati, OH, 2UC Health, Cincinnati, OH

    *Purpose: High tacrolimus (TAC) intrapatient variability (IPV) is associated with poorer outcomes. Manual monitoring of TAC IPV is labor intensive and not always feasible. As…
  • 2019 American Transplant Congress

    Impact of Case Scheduling on Hospital Cost and Length of Stay in Living Donor Kidney Recipients

    J. Yu1, L. A. Dageforde2, M. B. Doyle1, A. S. Khan1, W. C. Chapman1, Y. Lin1, S. Shenoy1, T. Alhamad3, T. A. Horwedel4, J. R. Wellen1

    1Surgery, Washington University School of Medicine, St. Louis, MO, 2Surgery, Massachusetts General Hospital, Boston, MA, 3Medicine, Washington University School of Medicine, St. Louis, MO, 4Barnes-Jewish Hospital, St. Louis, MO

    *Purpose: In an effort to optimize patient care and cost efficiency, we investigated if living donor kidney transplant (LDKT) recipients incurred any difference in hospital…
  • 2019 American Transplant Congress

    A Clinical Analysis for Low-Dose Immunoglobulin United with Plasmapheresis in High Sensitization Renal Transplantation Recipients

    L. Xu1, J. Zhang2

    1Chinese PLA General Hospital Eighth Medical Centre, Beijing, China, 2Nursing Department, Chinese PLA General Hospital, Beijing, China

    *Purpose: To analyze the role of low-dose intravenous immunoglobulin (IVIG) united with plasmapheresis in high sensitization renal transplantation recipients.*Methods: Four patients with high levels of…
  • 2019 American Transplant Congress

    Is HLA Donor-Specific Antibody (DSA)-C3d+ Assay a Potential Predictor of Subclinical Antibody Mediated Damage in the Renal Graft?

    A. G. Contreras1, M. I. Solis-G1, C. Ramirez-Espinoza1, J. Hernandez-Rosales2, M. Vilatoba-Chapa1, R. Cruz-Martínez1, J. Granados1, L. E. Morales-Buenrostro3, J. Alberú1, J. M. Arreola-Guerra4

    1Transplantation, Instituto Nacional de Ciencias Medicas y Nutricion SZ, Mexico City, Mexico, 2Department of Histocompatibility, Laboratorio Clinico del Campestre, Mexico City, Mexico, 3Nephrology-Mineral Metabolism, Instituto Nacional de Ciencias Medicas y Nutricion SZ, Mexico City, Mexico, 4Internal Medicine, Centenario Hospital Miguel Hidalgo, Mexico City, Mexico

    *Purpose: The Aim of the study was to explore the predictive value of the C3d assay for tissue damage in kidney transplant recipients (KTR) in…
  • 2019 American Transplant Congress

    Nivolumab-Induced Rejection of a Liver Allograft: PD-1 Inhibition Thwarts Liver Allograft Resistance to Humoral Rejection

    B. T. Lee, H. Han, S. Chopra, A. J. Ahearn

    Surgery, USC Keck School of Medicine, Los Angeles, CA

    *Purpose: Checkpoint inhibitor therapy with Programmed cell death protein (PD-1) inhibitors has recently been FDA approved for the treatment of several malignancies. However, it has…
  • « Previous Page
  • 1
  • …
  • 96
  • 97
  • 98
  • 99
  • 100
  • …
  • 214
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences